CD276 and breast cancer: In the QFU cohort, 50% of the cancers showed some degree of tumour cell specific expression (>1% tumour cells) of B7-H3 (Figure 2a), reaching 90% of cases in the metaplastic breast cancer subtype (n = 10; Figure 2b).